Gossamer Bio's total assets for Q1 2025 were $280.59M, a decrease of -11.01% from the previous quarter. GOSS total liabilities were $286.84M for the fiscal quarter, a 0.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.